Home › Funds › T. Rowe Price › Hedged Equity ETF
Fund family: T. Rowe Price · Filed by T. Rowe Price Exchange-Traded Funds, Inc. (CIK 1795351) · SEC series S000089786
Ticker: THEQ (C000256566)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,490 with, 109 against, 0 abstentions (not counted as with management). Shareholder proposals: 5 FOR, 104 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | T. Rowe Price | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 97.3% | 1,455 | 93.7% | 208,710 |
| Backed environmental and social shareholder proposals at US companies | 1.8% | 56 | 2.6% | 3,333 |
Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most T. Rowe Price funds on all 1,550 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 97.5% of this fund’s 1,599 such votes could be given a sector; the other 40 (2.5%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Technology | 367 | 29 | 7.9% |
| Consumer Discretionary | 247 | 31 | 12.6% |
| Health Care | 245 | 14 | 5.7% |
| Utilities | 195 | 5 | 2.6% |
| Finance | 164 | 6 | 3.7% |
| Consumer Staples | 77 | 10 | 13.0% |
| Industrials | 77 | 3 | 3.9% |
| Telecommunications | 76 | 6 | 7.9% |
| Energy | 44 | 3 | 6.8% |
| Real Estate | 38 | 1 | 2.6% |
| Basic Materials | 29 | 1 | 3.4% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,155 | 0 |
| Say-on-Pay | 117 | 0 |
| Audit-related | 115 | 0 |
| Corporate Governance | 78 | 45 |
| Compensation | 50 | 2 |
| Environment or Climate | 25 | 25 |
| Other Social Issues | 21 | 21 |
| Capital Structure | 20 | 0 |
| Human Rights or Human Capital/workforce | 8 | 8 |
| Shareholder Rights and Defenses | 6 | 4 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Motorola Solutions, Inc. | May 18, 2026 | $119,091 | 10 | 0 |
| Cencora, Inc. | March 5, 2026 | $102,839 | 13 | 0 |
| Exxon Mobil Corporation | May 27, 2026 | $99,687 | 17 | 2 |
| Gilead Sciences, Inc. | April 30, 2026 | $96,694 | 15 | 3 |
| Merck & Co., Inc. | May 26, 2026 | $96,539 | 18 | 3 |
| Johnson & Johnson | April 23, 2026 | $88,246 | 15 | 1 |
| Duke Energy Corporation | May 7, 2026 | $88,011 | 17 | 0 |
| Colgate-Palmolive Company | May 8, 2026 | $87,655 | 14 | 2 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 27, 2026 | Exxon Mobil Corporation | Independent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000 Shareholder proposal | Against | For |
| May 27, 2026 | Exxon Mobil Corporation | Proposal requesting Company to modify its Voluntary Retail Voting Program to provide multiple options not aligned with the Board's recommendations Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | Against | For |
| May 8, 2026 | Colgate-Palmolive Company | Stockholder proposal entitled "Remove DEI from Board Candidate Considerations." Shareholder proposal | Against | For |
| May 8, 2026 | Colgate-Palmolive Company | Stockholder proposal entitled "Independent Board Chairman." Shareholder proposal | Against | For |
| June 16, 2026 | Mastercard Incorporated | Consideration of a stockholder proposal regarding shareholder right to act by written consent Shareholder proposal | Against | For |
| June 16, 2026 | Mastercard Incorporated | Consideration of a stockholder proposal to adopt cumulative voting for the election of directors Shareholder proposal | Against | For |
| May 6, 2026 | Philip Morris International Inc. | Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposal | Against | For |
1,604 ballot items at 118 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Hedged Equity ETF (THEQ) voted at 118 shareholder meetings of 116 companies, on 1,604 ballot items in all. Where management made a recommendation, the fund followed it on 93.2% of the items and voted against it 109 times. Its most frequent area of disagreement was corporate governance (45 of its votes against management). It voted FOR 4.6% of the 109 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than T. Rowe Price's funds as a whole (97.3% against 93.7%). It voted the same way as most T. Rowe Price funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.